Regardless of age, frailty is a strong risk factor for dying prematurely after a kidney transplant. The finding, which comes from a new study published in the American Journal of Transplantation, suggests that patients should be screened for frailty prior to kidney transplantation, and that those who are identified as frail should be closely monitored after the procedure.
It's very difficult for physicians to identify which patients with kidney disease will not do well after receiving a kidney transplant. Even the best models are able to correctly discriminate patients who died soon after the procedure from those who survived only slightly better than chance.
Because studies in patients undergoing various surgeries have found that frailty is linked with postoperative complications and other negative outcomes, Mara McAdams-DeMarco, PhD, of Johns Hopkins University's School of Public Health and School of Medicine, and her colleagues looked to see if frailty might also impact patients' survival after receiving a kidney transplant.
The researchers measured frailty in 537 kidney transplant recipients at the time of transplantation. At 5 years, the survival rates were 91.5 percent, 86.0 percent, and 77.5 percent for non-frail, intermediately frail, and frail kidney transplant recipients, respectively.
"Our results suggest that frail kidney transplant recipients are at twice the risk of mortality even after accounting for important recipient, transplant, and donor characteristics," said Dr. McAdams-DeMarco. "Our findings are important because frailty represents a unique domain of mortality risk that is not captured by recipient, transplant, or donor factors like recipient age, recipient comorbidity, or donor type, for example." She noted that frailty can easily be measured prior to transplantation to identify patients who may benefit from closer monitoring.
This study is published in the American Journal of Transplantation. Media wishing to receive a PDF of this article may contact firstname.lastname@example.org.
Full citation: "Frailty and Mortality in Kidney Transplant Recipients." Mara A. McAdams-DeMarco, Andrew Law, Elizabeth King, Babak Orandi, Megan Salter PhD, Natasha Gupta, Eric Chow, Nada Alachkar, Niraj Desai, Ravi Varadhan, Jeremy Walston, and Dorry Segev. American Journal of Transplantation; Published
Online: October 30, 2014 (DOI: 10.1111/ajt.12992).
URL Upon Publication: http://doi.
About the Journal
American Journal of Transplantation (AJT) is the official journal of the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS). This #1 ranked transplantation journal serves as a forum for debate and re-assessment and is a major platform for promoting understanding, improving results and advancing science in this dynamic field. Published monthly, AJT provides an essential resource for researchers and clinicians around the world. Find out more at http://www.
Wiley is a global provider of content-enabled solutions that improve outcomes in research, education, and professional practice. Our core businesses produce scientific, technical, medical, and scholarly journals, reference works, books, database services, and advertising; professional books, subscription products, certification and training services and online applications; and education content and services including integrated online teaching and learning resources for undergraduate and graduate students and lifelong learners.
Founded in 1807, John Wiley & Sons, Inc. (NYSE: JWa, JWb), has been a valued source of information and understanding for more than 200 years, helping people around the world meet their needs and fulfill their aspirations. Wiley and its acquired companies have published the works of more than 450 Nobel laureates in all categories: Literature, Economics, Physiology or Medicine, Physics, Chemistry, and Peace. Wiley's global headquarters are located in Hoboken, New Jersey, with operations in the U.S., Europe, Asia, Canada, and Australia. The Company's website can be accessed at http://www.